Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye — PRAVA

Retinopathy, Diabetic Clinical Trial

Official title:
The Evaluation of Retinal PhotoReceptors And Vasculature in Moderate and Severe Non-proliferative Diabetic Retinopathy Patients After Intravitreal Aflibercept on Using Adaptive Optics Imaging Study (PRAVA) Study

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to specifically assess the effect of intravitreal aflibercept injections on the health of cells and the flow of blood through the retinal blood vessels by using advanced technology called adaptive optics.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04702048
Study type	Interventional
Source	University of Rochester
Contact
Status	Withdrawn
Phase	Phase 4
Start date	February 1, 2021
Completion date	February 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06066021` - Evaluation of a Health Education Program for Type 2 Diabetes Patients	N/A
Recruiting	`NCT06376240` - The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes	N/A
Completed	`NCT01506895` - A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema	Phase 2
Recruiting	`NCT04025996` - REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus
Recruiting	`NCT04362241` - DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery	Phase 4
Completed	`NCT03345667` - Assessment of Color Vision in Diabetic Patients	N/A
Recruiting	`NCT05746975` - Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR)